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 Encephalitis, infl ammation of the brain, is most commonly 
caused by a viral infection (especially herpes simplex virus 
[HSV] type 1 in the UK) although autoimmune causes, such as 
N-methyl D-aspartate receptor (NMDAR) antibody encepha-
litis, are increasingly recognised. Most patients present with 
a change in consciousness level and may have fever, seizures, 
movement disorder or focal neurological defi cits. Diagnosis 
hinges crucially on lumbar puncture and cerebrospinal fl uid 
(CSF) examination, but imaging and electroencephalography 
(EEG) may also be helpful. Treatment of HSV encephalitis with 
aciclovir dramatically improves outcome, but the optimal man-
agement of autoimmune encephalitis is still uncertain. Many 
patients with encephalitis are left with residual physical or 
neuropsychological defi cits which require long-term multidis-
ciplinary management. Here we review assessment of patients 
with suspected encephalitis, general aspects of management 
and areas of ongoing research. 
 Introduction: defi nitions and importance 
 Acute encephalitis is a neurological emergency which can 
cause severe disability or death, but can often be treated if 
diagnosed promptly. Strictly, encephalitis is a pathological entity 
meaning inflammation of the brain, but this can be ascertained 
clinically by assessing proxy markers: cerebrospinal fluid (CSF) 
parameters, imaging or electroencephalogram (EEG) ( Box 1 ). 
There are approximately 6000 cases of encephalitis in the UK 
annually, 1 so most district general hospitals might expect several 
cases per year. However, unlike more common conditions such 
as stroke, which has dedicated units providing multifaceted 
management, patients with encephalitis are not usually 
looked after by specialist teams, presenting significant clinical 
challenges. 
 The typical patient presenting with encephalopathy is referred 
to the acute medicine team, but there are often significant 
delays in the suspicion of encephalitis being raised. 2 The urgent 
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 Key points 
 Undertaking a lumbar puncture is vital to distinguish encephalitis 
from encephalopathy, and therefore to guide management 
 Imaging is not required before lumbar puncture unless a specific 
contraindication is present (see Fig  1 ) 
 Aciclovir is a time-critical life-saving treatment for HSV 
encephalitis and should be commenced before lumbar puncture 
if this is delayed for any reason 
 Investigation and management of suspected autoimmune 
encephalitis should be undertaken in consultation with a 
neurologist 
 Many patients with encephalitis will have residual physical 
and neuropsychological issues and require a multidisciplinary 
approach to their ongoing care 
 KEYWORDS :  encephalitis ,  encephalopathy ,  confusion ,  lumbar 
puncture ,  brain infection ■ 
 Box 1.  Definitions (as used in research studies) 4 
Encephalopathy = (altered consciousness persisting for 
longer than 24 h, including lethargy, irritability or a change in 
personality or behaviour)
Encephalitis = encephalopathy AND evidence of CNS 
inflammation, demonstrated by at least two of:
 > fever
 >  seizures or focal neurological findings attributable to the 
brain parenchyma
 > CSF pleocytosis (more than 4 white cells per μL)
 > EEG findings suggestive of encephalitis
 > neuroimaging findings suggestive of encephalitis.
CNS = central nervous system; CSF = cerebrospinal fluid; EEG = 
electroencephalography
and to rule out potentially life-threatening diagnoses, including 
HSV type 1 encephalitis which can kill rapidly and needs urgent 
antiviral treatment. Making this diagnosis hinges crucially on 
lumbar puncture (LP), which in practice is often delayed. 3 Once 
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a treatable viral cause is excluded, autoimmune encephalitis 
may be considered, but tests for these conditions take longer to 
perform. Even with thorough investigation, between 37% and 
62% of patients with encephalitis will have no identified cause, 4,5 
and the management of this group remains challenging. 
 This article aims to cover current practice in encephalitis in 
adults, from the front door of the emergency department to the 
point when a specialist referral to neurology or infectious diseases 
may be made. 
 Clinical assessment and investigations 
 Confusion is a common presentation to the acute medical 
unit and has a wide differential diagnosis ( Box 2 ). The clinical 
challenge is distinguishing causes of encephalopathy, including 
septic, metabolic, toxic and others, from patients who have 
encephalitis and therefore need specific treatments. Initial 
history should identify clues as to possible causes, including 
a full collateral history if available, in order to ascertain the 
true duration of the problem. Evidence should be sought of a 
change in personality or behaviour, or periods of drowsiness 
or seizures (which may be subtle). A travel history should 
be obtained, including any contact with animals, fresh 
water, mosquito or tick bites, or exposure to illnesses in the 
community. Known immunocompromise or risk factors for HIV 
infection should be established. Examination should establish 
conscious level, any focal neurological deficit, seizure activity or 
movement disorder. 
 The key to establishing evidence of central nervous system (CNS) 
inflammation is the analysis of CSF. Lumbar puncture (LP) is often 
excessively delayed, primarily due to performing brain imaging to 
exclude raised intracranial pressure. 3 Not all patients need imaging 
before LP, and consensus guidelines suggest a few clear indications 
for imaging (Fig  1 ). 6 – 8 If these are present, then either a computed 
tomography (CT) scan or, ideally, magnetic resonance imaging 
(MRI) should be obtained urgently. Following this, if there are no 
radiological contraindications, LP should be performed as soon as 
possible. Brain imaging serves three purposes: to look for changes 
of encephalitis, to exclude alternative diagnoses, and to assess 
patency of the basal cisterns and an absence of mass effect so 
that LP can proceed. 
 The key tests that should be requested on CSF are outlined in Fig 
 1 . In viral encephalitis there is typically a CSF pleocytosis (>5 white 
cells x 10 9 /L), comprising predominantly lymphocytes. However, 
early in the illness neutrophils can predominate, or occasionally the 
white cell count may be normal. 9 Protein is normal to moderately 
raised and glucose is normal. Polymerase chain reaction (PCR) for 
the most frequent viral causes should yield results within 24–48 
hours from most laboratories. Cerebrospinal fluid PCR for HSV 
has a sensitivity and specificity of over 95% for HSV encephalitis 
in immunocompetent adults. 10 In some cases where CSF is 
obtained very early in the disease course, PCR for HSV can be 
falsely negative. Therefore, if clinical suspicion of HSV remains, 
LP should be repeated and will often be positive, despite aciclovir 
treatment. 11 
 Magnetic resonance imaging is the gold standard technique 
for brain imaging in encephalitis, 12 and is abnormal in 90% 
of cases of HSV encephalitis, 4 but may be normal or subtly 
abnormal in autoimmune encephalitis (Fig  2 ). 13 Further imaging 
techniques including ultrasonography, CT of the body and 
positron emission tomography (PET) imaging may be indicated 
if a paraneoplastic cause is suspected 14 (for example in N-methyl 
D-aspartate receptor [NMDAR] antibody encephalitis, which 
may be associated with ovarian teratoma in young females). 15 
Electroencephalography is useful in identifying and monitoring 
seizure activity, but is non-specific and can be abnormal in a 
number of other causes of encephalopathy. 
 All patients with suspected brain infection should have an 
HIV test. Meningoencephalitis can occur at the time of HIV 
seroconversion 16 and immunocompromise vastly alters the 
differential diagnosis. Since HIV serology may be negative at 
seroconversion, if there is clinical suspicion HIV RNA testing should 
be requested. 17 
 If tests for an infective cause are negative, or if patients 
present with a recognisable phenotype of autoimmune 
encephalitis at the outset, then autoantibody testing should 
be considered. 18 The number of antibodies associated with 
encephalitis is expanding rapidly, but the best recognised 
phenotypes are those of NMDAR antibody encephalitis and LGI-1 
antibody encephalitis (a subunit of the voltage-gated potassium 
channel). The decision of which tests to send is best made in 
consultation with a neurologist. 
 The role of brain biopsy in the diagnosis of encephalitis has 
declined since the advent of PCR testing in CSF and it does not 
form part of the initial assessment. However, it still has a place 
for patients in whom diagnosis has not been obtained following 
extensive investigation, particularly if there are focal abnormalities 
on imaging. 19 
 Box 2.  Most common causes and mimics of 
encephalitis in immunocompetent adults in the UK 
Causes : 
 Viral : Herpes simplex virus types 1 and 2, varicella zoster virus, 
enteroviruses, adenovirus, parechovirus, measles virus, HIV
 Autoimmune (main tumour associations in brackets) : 
Antibodies against neuronal surface antigens: NMDAR antibody 
encephalitis (ovarian teratoma), LGI-1 antibody encephalitis 
(thymoma), antibodies against intracellular antigens: anti-Hu 
(small cell lung tumour), anti-Ma (testicular tumours), anti-GAD, 
acute disseminated encephalomyelitis, Bickerstaff's encephalitis
 Mimics: 
 Infective : Systemic sepsis with encephalopathy, bacterial 
meningitis, TB, opportunistic infections in immunocompromised 
patients (eg crytococcus, toxoplasma, cytomegalovirus)
 Inflammatory : Vasculitis, systemic lupus erythematosus with 
CNS involvement, Behçet's disease, neurosarcoidosis
 Metabolic : Hypoglycaemia, hyponatraemia, hepatic 
encephalopathy, toxins (drugs, alcohol)
 Neoplastic : Primary brain tumour (particularly low grade glioma 
mimicking CNS inflammation), metastases
 Others : Status epilepticus from other causes, haemorrhagic or 
ischaemic stroke, psychiatric disease
CNS = central nervous system; GAD = glutamic acid decarboxylase; LGI-1 = 
leucin-rich glioma inactivated 1; NMDAR = N-methyl D-aspartate receptor; TB 
= tuberculosis
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Clinical features of encephalis




















CSF PCR for HSV posive?
Aciclovir treatment for 14 days then repeat LP Alternave microbiological diagnosis Treat as appropriate
Consider autoimmune encephalis, parcularly if subacute
onset (progression of less than 3 months)
of working memory deficits, altered mental status, or psychiatric symptoms
Seek neurology advice
Start empirical aciclovir. Reconsider LP in 24 h
Contraindicaons to immediate LP
Indicaons for neuroimaging before lumbar
puncture (LP) in suspected encephalisa
Focal neurological signs
Presence of papilloedemab
Connuous or uncontrolled seizures
GCS ≤ 12c
ato exclude significant brain swelling and shi that may
predispose to cerebral herniaon post LP
binability to view the fundus is not a contraindicaon to LP,
especially in paents who have had a short duraon of symptoms
cLP without prior neuroimaging may be safe at levels below this
 Fig 1.  Algorithm for basic management of acute encephalitis (based on UK guidelines). 6 CSF = cerebrospinal fl uid; GCS = Glasgow Coma Scale; HSV = 
herpes simplex virus; LP = lumbar puncture; VZV = varicella zoster virus 
 Fig 2.  Brain imaging in encephalitis. (a) CT scan of 69-year-old male with acute HSV-1 encephalitis showing low intensity area in right temporal lobe.  (b) T2 
weighted axial MRI from same patient showing bilateral asymmetrical signal abnormality in medial temporal lobes.  (c) T2 weighted axial MRI of 55-year-old 
male with LGI-1 antibody encephalitis showing high signal in the left medial temporal lobe. (d) Coronal T2 FLAIR from same patient showing high signal in 
left medial temporal lobe. CT = computed tomography; FLAIR = fl uid attenuation inversion recovery; HSV = herpes simplex virus; LGI-1 = leucin-rich glioma 
inactivated 1; MRI = magnetic resonance imaging 
CMJv18n2-CMEEllul.indd   157 3/24/18   3:29 PM
158 © Royal College of Physicians 2018. All rights reserved.
CME Infectious diseases
 Key aspects of management 
 Intravenous aciclovir is a life-saving treatment in HSV encephalitis 
and has reduced mortality from above 70% to around 10–
20%. 20,21 It is relatively safe, although there is a small risk of renal 
impairment owing to a crystal nephropathy. 22 Renal function 
should be monitored; in patients with known renal impairment the 
dose should be reduced. 
 Ideally, LP should be performed immediately in patients with 
suspected brain infection, and empirical treatment started 
immediately thereafter. However, if LP is delayed for more than 
6 hours empirical aciclovir may be needed before LP. 6 Patients 
with HSV encephalitis are likely to remain PCR positive in CSF 
for at least the first few days after commencing treatment, 
so LP should still be performed as soon as possible in patients 
who have commenced aciclovir. This will help to establish the 
diagnosis and therefore dictate the duration of treatment. The 
UK guidelines recommend that aciclovir should be continued for 
at least 2 weeks, at which point the LP should be repeated. If 
the HSV PCR is still positive, aciclovir should be continued with 
repeat LP every week until the PCR is negative. 6 If the patient 
is completely well, some would suggest that repeat LP is not 
necessary. 23 
 The management of autoimmune encephalitis with immune 
therapy is non-standardised and based on evidence from 
retrospective studies. 24 For initial therapy, most neurologists 
use corticosteroids intravenously or orally. Intravenous 
immunoglobulin or plasma exchange are often also used, 
especially in those failing to improve. Patients should be 
investigated thoroughly for underlying malignancy, as a 
proportion of cases are paraneoplastic. 25 The available evidence 
suggests that early treatment improves outcome, and that, if 
initial therapy is ineffective, second-line therapy with more potent 
agents is beneficial. 26 
 Of patients with encephalitis, 50–60% have seizures in the acute 
phase, which may be clinically subtle, 4,5,27 and seizure control is a 
key aspect of management. 
 The care of patients with encephalitis is challenging for nursing 
staff. Patients often have physical, neuropsychological and 
communication difficulties which make interaction with their 
environment and their relatives demanding. Most patients with 
encephalitis are left with some degree of neuropsychological 
impairment, 28 and the prevalence of attentional, behavioural and 
emotional disorders in survivors remains high up to 3 years after 
diagnosis. 29 Access to neuropsychology services can be invaluable in 
assisting with memory difficulties and other psychological changes 
in encephalitis. 30 Patients and relatives often only hear about 
encephalitis for the first time when they are diagnosed, and giving 
them access to reliable information about the condition can be 
empowering (eg via the Encephalitis Society  www.encephalitis.info ). 
 New directions and areas of uncertainty 
 The advent of aciclovir therapy in the 1980s revolutionised the 
outcome of HSV encephalitis. However, patients are still dying 
of the condition and many survivors are left with debilitating 
sequelae. There is accumulating evidence that the pathogenesis 
of HSV encephalitis is intimately connected to the degree of host 
inflammatory response to the virus. 31 For some years evidence 
from  in vitro and animal models has suggested that the addition 
of corticosteroids to aciclovir for the treatment of HSV encephalitis 
may improve outcome. 32–34 A multicentre trial is addressing this 
question ( www.dexenceph.org.uk ). 
 Autoimmune encephalitis mediated by antibodies directed 
against neuronal components has been newly described in 
the last decade, and the various antibody targets and clinical 
phenotypes are still being clarified, including the concept that in 
some cases autoimmune encephalitis may be triggered by a prior 
viral encephalitis. 35 The optimal management of autoimmune 
encephalitis is still unclear. 24 Key questions, such as whether 
intravenous immunoglobulin is beneficial as a first line therapy, 
remain to be clarified by randomised controlled trials. 
 Despite thorough investigation for infective and autoimmune 
causes, between 37 and 62% of patients with encephalitis 
do not have an aetiological cause established. 4,5 Novel 
laboratory techniques, including proteomics, transcriptomics 
and metabolomics, offer the hope that immune responses in 
encephalitis will be elucidated, and this may help to stratify 
unknown patients into aetiological groups. In addition, the search 
for putative infective agents using next-generation sequencing, 
and novel antibodies using protein arrays and mass spectrometry, 
may provide a diagnosis for more patients in the future. ■ 
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